Cardiovascular-Related Mortality Risk in Primary Myelofibrosis in Pre-Ruxolitinib and Ruxolitinib Eras

被引：0

作者：

Ilerhunmwuwa, Nosakhare Paul ^{[1
]}

Rayapureddy, Aditya Keerthi ^{[2
]}

Uche, Ifeanyi Nnamdi ^{[1
]}

Wasifuddin, Mustafa ^{[3
]}

Wang, Jen-Chin ^{[4
]}

机构：

[1] Brookdale Univ Hosp & Med Ctr, Dept Med, Brooklyn, NY USA

[2] Interfaith Med Ctr, Dept Med, Brooklyn, NY USA

[3] Brookdale Univ Hosp & Med Ctr, Brooklyn, NY USA

[4] Brookdale Univ Hosp & Med Ctr, Div Hematol Oncol, Brooklyn, NY USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-174418

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[41] Navitoclax in Combination with Ruxolitinib in Patients with Primary or Secondary Myelofibrosis: A Phase 2 Study [J].

Harrison, Claire ;

Garcia, Jacqueline S. ;

Mesa, Ruben ;

Somervaille, Tim ;

Ritchie, Ellen K. ;

Komrokji, Rami S. ;

Pemmaraju, Naveen ;

Jamieson, Catriona ;

Papadantonakis, Nikolaos ;

Foran, James M. ;

O'Connell, Casey L. ;

Verstovsek, Srdan ;

Jung, Paul ;

Holes, Leanne ;

Masud, Abdullah ;

Harb, Jason ;

Hutti, Jessica E. ;

Prchal, Josef T. .

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 :S325-S325

[42] Second primary malignancies in patients receiving treatment with ruxolitinib for myelofibrosis - a regional experience [J].

Schofield, J. ;

Wells, R. ;

Nicholson, T. ;

Butt, N. M. .

BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 :77-77

[43] The impact of ruxolitinib treatment on inflammation-mediated comorbidities in myelofibrosis and related neoplasms [J].

Bjorn, Mads Emil ;

Hasselbalch, Hans Carl .

CLINICAL CASE REPORTS, 2015, 3 (06) :499-503

[44] SAFETY AND EFFICACY OF RUXOLITINIB IN AN ELDERLY PATIENT WITH PRIMARY MYELOFIBROSIS AND ACTIVE HCV AND HBV RELATED-LIVER DISEASE [J].

De Lorenzo, S. ;

Barone, M. ;

Rivellini, F. ;

Petrizzi, V. Belsito ;

Califano, C. ;

Langella, M. ;

Iovino, V. ;

Campana, A. ;

De Prisco, P. ;

Ingenito, C. ;

D'Arco, A. M. .

HAEMATOLOGICA, 2015, 100 :111-111

[45] Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis [J].

Francesca Palandri ;

Giuseppe Alberto Palumbo ;

Elena Maria Elli ;

Nicola Polverelli ;

Giulia Benevolo ;

Bruno Martino ;

Elisabetta Abruzzese ;

Mario Tiribelli ;

Alessia Tieghi ;

Roberto Latagliata ;

Francesco Cavazzini ;

Micaela Bergamaschi ;

Gianni Binotto ;

Monica Crugnola ;

Alessandro Isidori ;

Giovanni Caocci ;

Florian Heidel ;

Novella Pugliese ;

Costanza Bosi ;

Daniela Bartoletti ;

Giuseppe Auteri ;

Daniele Cattaneo ;

Luigi Scaffidi ;

Malgorzata Monica Trawinska ;

Rossella Stella ;

Fiorella Ciantia ;

Fabrizio Pane ;

Antonio Cuneo ;

Mauro Krampera ;

Gianpietro Semenzato ;

Roberto Massimo Lemoli ;

Alessandra Iurlo ;

Nicola Vianelli ;

Michele Cavo ;

Massimo Breccia ;

Massimiliano Bonifacio .

Blood Cancer Journal, 11

[46] Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis [J].

Palandri, Francesca ;

Palumbo, Giuseppe Alberto ;

Elli, Elena Maria ;

Polverelli, Nicola ;

Benevolo, Giulia ;

Martino, Bruno ;

Abruzzese, Elisabetta ;

Tiribelli, Mario ;

Tieghi, Alessia ;

Latagliata, Roberto ;

Cavazzini, Francesco ;

Bergamaschi, Micaela ;

Binotto, Gianni ;

Crugnola, Monica ;

Isidori, Alessandro ;

Caocci, Giovanni ;

Heidel, Florian ;

Pugliese, Novella ;

Bosi, Costanza ;

Bartoletti, Daniela ;

Auteri, Giuseppe ;

Cattaneo, Daniele ;

Scaffidi, Luigi ;

Trawinska, Malgorzata Monica ;

Stella, Rossella ;

Ciantia, Fiorella ;

Pane, Fabrizio ;

Cuneo, Antonio ;

Krampera, Mauro ;

Semenzato, Gianpietro ;

Lemoli, Roberto Massimo ;

Iurlo, Alessandra ;

Vianelli, Nicola ;

Cavo, Michele ;

Breccia, Massimo ;

Bonifacio, Massimiliano .

BLOOD CANCER JOURNAL, 2021, 11 (01)

[47] Impact of Pre-Graft Ruxolitinib on Post-Transplantation Outcome in Myelofibrosis Patients [J].

Villar, Sara ;

Chevret, Sylvie ;

Poire, Xavier ;

Charbonnier, Amandine ;

Chevallier, Patrice ;

Bourhis, Jean-Henri ;

Forcade, Edouard ;

Chantepie, Sylvain ;

Beauvais, David ;

Raus, Nicole ;

Bay, Jacques-Olivier ;

Loschi, Michael ;

Devillier, Raynier ;

Duléry, Remy ;

Ceballos, Patrice ;

Rubio, Marie Thérèse ;

Beguin, Yves ;

Nguyen, Stephanie ;

Robin, Marie .

BLOOD, 2021, 138 :1844-+

[48] Ruxolitinib Treatment in a Patient with Primary Myelofibrosis Resistant to Conventional Therapies and Splenectomy: A Case Report [J].

Ayh, Meltem ;

Ozcan, Muhit ;

Seval, Guldane Cengiz .

TURKISH JOURNAL OF HEMATOLOGY, 2015, 32 (02) :180-183

[49] Acute respiratory distress syndrome in a patient with primary myelofibrosis after ruxolitinib treatment discontinuation [J].

Yan Beauverd ;

Kaveh Samii .

International Journal of Hematology, 2014, 100 :498-501

[50] Osteolytic Lesions in Primary Myelofibrosis and Effect of Ruxolitinib Therapy: Report of a Case and Literature Review [J].

Bucelli, Cristina ;

Cattaneo, Daniele ;

Valli, Viviana Beatrice ;

Levati, Giorgia Virginia ;

Lonati, Silvia ;

Gianelli, Umberto ;

Iurlo, Alessandra .

CHEMOTHERAPY, 2018, 63 (06) :340-344

← 1 2 3 4 5 →